{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T13:53:07Z","timestamp":1783518787391,"version":"3.55.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31860309"],"award-info":[{"award-number":["31860309"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003850","name":"Inner Mongolia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020788","name":"Science and Technology Major Project of Inner Mongolia Autonomous Region of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020788","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jinorgbio.2025.113049","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T23:12:21Z","timestamp":1756509141000},"page":"113049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Acetylated monosaccharide functionalized co-ligand based strong anticancer Pt(II) complexes: Synthesis characterization and biological analyses"],"prefix":"10.1016","volume":"274","author":[{"given":"Na","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fufu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-fang","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz-Ur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2025.113049_bb0005","doi-asserted-by":"crossref","first-page":"2300253","DOI":"10.1002\/adhm.202300253","article-title":"Recent advances of platinum-based anticancer complexes in combinational multimodal therapy","volume":"12","author":"Zhong","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0010","article-title":"The power of kinetic inertness in improving platinum anticancer therapy by circumventing resistance and ameliorating nephrotoxicity","volume":"62","author":"Panda","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"issue":"18","key":"10.1016\/j.jinorgbio.2025.113049_bb0015","first-page":"2075","article-title":"Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches","volume":"12","author":"Galanski","year":"2005"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0020","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ccr.2016.03.008","article-title":"More of a misunderstanding than a real mismatch? Platinum and its affinity for aqua, hydroxido, and oxido ligands","volume":"327\u2013328","author":"Lippert","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ica.2019.118974","article-title":"Biological relevance of interaction of platinum drugs with O-donor ligands","volume":"495","author":"Gorle","year":"2019","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0030","doi-asserted-by":"crossref","first-page":"9494","DOI":"10.1002\/chem.201403066","article-title":"Rationalizing the structural variability of the exocyclic amino groups in nucleobases and their metal complexes: cytosine and adenine","volume":"20","author":"Fonseca","year":"2014","journal-title":"Chemistry"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0035","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccr.2015.11.004","article-title":"New trends in platinum and palladium complexes as antineoplastic agents","volume":"310","author":"Fanelli","year":"2016","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188577","article-title":"Pathogenesis and therapeutic strategy in platinum resistance lung cancer","volume":"1876","author":"Lv","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA) - Rev. Cancer"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ejmech.2017.09.034","article-title":"Research progress in modern structure of platinum complexes","volume":"140","author":"Bai","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114045","article-title":"Cisplatin-induced ototoxicity: from signaling network to therapeutic targets","volume":"157","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0055","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.7150\/thno.69424","article-title":"Platinum-based drugs for cancer therapy and anti-tumor strategies","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0060","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0065","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/cmdc.202000456","article-title":"Glycoconjugated metal complexes as Cancer diagnostic and therapeutic agents","volume":"16","author":"Bononi","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0070","series-title":"Understanding the Warburg Effect in Cancer","first-page":"a041532","author":"Li","year":"2024"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0075","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/cancers3021550","article-title":"Epigenetic regulation of glucose transporters in non-small cell lung cancer","volume":"3","author":"O\u2019Byrne","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0080","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.omto.2020.06.012","article-title":"Monocarboxylate transporter 4 is a therapeutic target in non-small cell lung Cancer with aerobic glycolysis preference","volume":"18","author":"Kuo","year":"2020","journal-title":"Molecular Therapy - Oncolytics"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0090","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2023.153475","article-title":"Inhibitory effects of flavonoids on glucose transporter 1 (GLUT1): from library screening to biological evaluation to structure-activity relationship","volume":"488","author":"Sun","year":"2023","journal-title":"Toxicology"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0100","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the Warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0105","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/febs.14577","article-title":"Glucose transporters in cancer-from tumor cells to the tumor microenvironment","volume":"285","author":"Ancey","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0110","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.3390\/molecules24112159","article-title":"Conformational studies of glucose transporter 1 (GLUT1) as an anticancer drug target","volume":"24","author":"Almahmoud","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0115","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1021\/acsmedchemlett.2c00250","article-title":"Aroylhydrazone glycoconjugate prochelators exploit glucose transporter 1 (GLUT1) to target iron in cancer cells","volume":"13","author":"Sung","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0120","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.2174\/092986708785908978","article-title":"Carbohydrate-metal complexes and their potential as anticancer agents","volume":"15","author":"Hartinger","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0125","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/S0960-894X(01)00623-0","article-title":"Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-Diamminedichloroplatinum(II) complexes","volume":"11","author":"Mikata","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0130","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/cmdc.200600279","article-title":"A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?","volume":"2","author":"Berger","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejmech.2016.01.016","article-title":"Galactose conjugated platinum(II) complex targeting the Warburg effect for treatment of non-small cell lung cancer and colon cancer","volume":"110","author":"Wu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0140","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1080\/07391102.2015.1114972","article-title":"2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity","volume":"34","author":"Mi","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0145","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/anie.201510551","article-title":"A Potent Glucose\u2013Platinum Conjugate Exploits Glucose Transporters and Preferentially Accumulates in Cancer Cells","volume":"55","author":"Patra","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0150","doi-asserted-by":"crossref","first-page":"5736","DOI":"10.1021\/acs.jmedchem.7b00433","article-title":"Glycosylated platinum(IV) complexes as substrates for glucose transporters (GLUTs) and organic cation transporters (OCTs) exhibited Cancer targeting and human serum albumin binding properties for drug delivery","volume":"60","author":"Ma","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0155","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1039\/c3cc38589b","article-title":"Highly water-soluble platinum(ii) complexes as GLUT substrates for targeted therapy: improved anticancer efficacy and transporter-mediated cytotoxic properties","volume":"49","author":"Liu","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0160","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1039\/C6DT01562J","article-title":"Design, synthesis and biological evaluation of a novel series of glycosylated platinum(IV) complexes as antitumor agents","volume":"45","author":"Wang","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0165","first-page":"3448","article-title":"Glycosylated BODIPY- incorporated Pt(II) Metallacycles for targeted and synergistic chemo-photodynamic therapy","volume":"66","author":"Dur\u00e1n-Sampedro","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0170","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/chem.200802013","article-title":"Prospects of metal complexes peripherally substituted with sugars in biomedicinal applications","volume":"15","author":"Gottschaldt","year":"2009","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2024.112661","article-title":"Co-targeting CDK 4\/6 and C-MYC\/STAT3\/CCND1 axis and inhibition of tumorigenesis and epithelial-mesenchymal-transition in triple negative breast cancer by Pt(II) complexes bearing NH3 as trans-co-ligand","volume":"259","author":"Lv","year":"2024","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0180","doi-asserted-by":"crossref","first-page":"13871","DOI":"10.1039\/D4DT01243G","article-title":"Salicylaldehyde-derived piperazine-functionalized hydrazone ligand-based Pt(ii) complexes: inhibition of EZH2-dependent tumorigenesis in pancreatic ductal adenocarcinoma, synergism with PARP inhibitors and enhanced apoptosis","volume":"53","author":"Lv","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2024.126622","article-title":"Ancillary ligand modulation effect on crystallization, metal aquation, fluorescence, lipophilicity, electrochemistry and anticancer activities of Pt(II) complexes","volume":"417","author":"Zou","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113689","article-title":"Platinum complexes inhibit HER-2 enriched and triple-negative breast cancer cells metabolism to suppress growth, stemness and migration by targeting PKM\/LDHA and CCND1\/BCL2\/ATG3 signaling pathways","volume":"224","author":"Bai","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113920","article-title":"Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: ascribe possibilities of new antitumor strategies","volume":"227","author":"Bai","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0200","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ejmech.2018.12.052","article-title":"ONS-donor ligand based Pt(II) complexes display extremely high anticancer potency through autophagic cell death pathway","volume":"164","author":"Rahman","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2025.113049_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2020.108195","article-title":"Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment","volume":"498","author":"Fu","year":"2020","journal-title":"Carbohydr. Res."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013425002296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013425002296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:24:26Z","timestamp":1780410266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013425002296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0162013425002296"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2025.113049","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylated monosaccharide functionalized co-ligand based strong anticancer Pt(II) complexes: Synthesis characterization and biological analyses","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2025.113049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113049"}}